Aim: To test the hypothesis that open surgical synovectomy of the knee results in better long-term control of chronic inflammatory synovitis of the knee than arthroscopic synovectomy.

Method: To test this hypothesis a prospective clinical trial was carried out involving three groups of patients:- In Group I (22 cases in 18 patients) arthroscopic synovectomy was performed by a surgeon experienced in arthroscopy (Bartlett). In Group II (15 cases in 11 patients) open surgical synovectomy / debridement was performed (Rush). In Group III (10 cases in seven patients) arthroscopic lavage was carried without synovectomy (Rush) and this acted as a “control” group. The patients were followed up for some 10 years. At the final review the clinical and functional scores were recorded using the H.S.S. knee score system. There are obvious problems in comparing two or three groups of patients from two separate units and these are discussed.

Results: The results showed that in both groups (i.e. Groups I & II) there was a significant shift to the right in the clinical and functional scores. This did not occur in the “control” group. In Group I, two cases out of 22 came to total knee replacement. In Group II, four cases out of 15 and in Group III, five cases out of 10 came to knee replacement.

Conclusions: It was concluded that knee synovectomy was a worthwhile procedure and that arthroscopic synovectomy was just as good and probably better than open surgical synovectomy but it needs to be done early and by a surgeon with experience in carrying out this difficult procedure.

Of 1197 renal transplant recipients on the Oxford Transplant Programme, 25 (2%) needed arthroplasties for painful osteonecrosis of the hip. Nine of them had bilateral operations, giving a total of 34 primary total hip replacements (THR). The mean time from onset of symptoms to THR was 2.4 years and from transplantation to THR 5.1 years. The mean follow-up was 5.1 (1 to 14) years. THR relieved the pain in all the patients, but survival analysis indicated a lower survival rate than is usual for primary THR. There were eight major complications. One graft-related problem, early acute tubular necrosis, resolved rapidly after immediate treatment. One patient developed deep infection at 3.5 years after THR which settled with conservative treatment. Five hips developed aseptic loosening requiring revision arthroplasty at a mean of 8.8 years' follow-up. One patient had a non-fatal pulmonary embolism. THR is the treatment of choice for patients with painful osteonecrosis of the hip after renal transplant, but has higher rates of both early and late complications. Surgery should be performed in close association with a renal transplant unit.